Itching to analyze cryptocurrency data down to the tick? Kaiko’s rich historical data—accessible through the Lippincott Library—offer details from more than 50 exchanges and 7,500 currency pairs, letting you expand the boundaries of your research.Continue reading
Microfinance data is hard to come by since reporting requirements for Microfinance Institutions (MFIs) are not well-developed or consistent across countries. MIX Market focuses exclusively on providing information related these institutions, and their MIX Intelligence subscription lets you find information on specific institutions or screen for institutions using a wide range of criteria. [Note: MIX Intelligence is not licensed for use outside the library, so you will have to visit Lippincott Library to use it. Just ask at our Information Desk for assistance with logging in.]
The Resources menu is the primary way to navigate to reports, data and tools in MIX Market. The easiest option is to select Profiles to look for a specific Financial Services Provider (FSP) or to screen for organizations by region, country and type. Profiles have top level information about organizations. This includes typical directory information, such as address, contact information and high level financials for the last three reported years, as well as links to annual reports if available. See the sample record below for CUMO, an MFI in Malawi.
The profile page also lets you to easily access the FSP (Financial Service Provider) Analysis data on that organization, where each option under Report Types allows you to select individual variables
Use the Cross Market Analysis function to select from more than 100 specific data points to compare, such as assets, administrative expenses, average loan balance per borrower, renegotiated loans, and many more. The additional filtering and grouping options allow you to create results like the table below, which shows the number of female active borrowers by country.
In addition to making tools available that you can use to create your own analyses, MIX publishes regular quarterly reports that include their analysis and visualization of data by country. These are generally produced on a quarterly basis and include country overviews called “factsheets” which include quarter-by-quarter performance across common variables such as average loan balance, number of active borrowers and portfolio-at-risk at the country level. Their “barometer forecasts” also provide forecast data from on a quarterly survey of FSPs. The snapshot on the left illustrates the projected borrower growth rates for Bangladesh.
Please see our Microfinance Research Guide for additional resources.
A recent article in Bloomberg News instantly grabbed my attention. Joe Montana, quarterback extraordinaire and football icon, now a venture capitalist, just participated in a $75 million funding for a company that sells marijuana products in stores throughout California. Taking a risk on a controversial investment, Joe is positioned to win in an industry which he hopes can make a “serious impact on opiod use or addiction”. In fact, cannabis related products could help football players or others in high impact, injury prone professions. This industry includes growers and retailers as well as medical and recreational products.
Like Joe, investors seem sweet on cannabis derived products that provide health and wellness benefits. But where is this industry headed as a business investment? How great is the risk? What are the opportunities? the library has a number of resources that can help to answer these questions.Continue reading
Lippincott Library is proud to announce the addition of Pitchbook to our list of business resources. Covering a vast array of data related to private capital markets, Pitchbook can provide the Wharton community with research information on private equity and venture capital. You will need to create an account, based on your Penn email address. There are download limitations: Each individual has 25 downloads per month and can use up to 10 in a day. Unlimited access using the API function in excel is available for public companies.
Market research reports from Euromonitor have always included strong coverage of the market for luxury goods and services around the world. Euromonitor is available through Lippincott Library using the Passport GMID database. Now available, Euromonitor has created a Wealth Index that will provide new information to those in the Penn community who are tracking opportunities in the luxury market. The Wealth Index ranks 84 countries on measures including:
- The population size and wealth of three consumer segments: Ultra High Net Worth Individuals, High Net Worth Individuals, and the Affluent
- Inconspicuous spending levels of the ultra wealthy
- The country’s proportion of homeowners without mortgage loans, savings levels, and more.
Lippincott Librarians sense trends as we help Penn students, faculty and staff dig for industry research, articles and data. In 2014, I worked with students researching machine vision and self-driving cars, and over the years, I have seen an increasing number of questions about the industry and technologies behind it. In 2019, I helped a student research Nuro, the Mountain View, California based robot delivery van company that has reached unicorn status, as reported in Inc. Just this week, Crunchbase reported that Uber is in talks for a $1B funding round for their self-driving car unit, a testament to how far businesses in this industry have come. As librarians, we observe industry life cycles through the support we offer to Penn.
Knowledge@Wharton recently featured a podcast with engineer Samuel I. Schwartz, author of No One at the Wheel: Driverless Cars and the Road of the Future, a book available through Van Pelt Library.
Think about your last friendly debate, mind-blowing lecture, or presidential tweet. Did someone make a quantitative claim that seemed hard to believe? If you can gather the data, you have the power to check the facts and come to your own evidence-based conclusion.
Let’s take an example: In the 2019 State of the Union Address, President Donald Trump stated, “the United States is now the number one producer of oil and natural gas in the world.”Continue reading
The FDA’s Center for Drug Evaluation and Research (CDER) approved a record 59 novel drugs in 2018 to treat diseases ranging from common illnesses like influenza to rare diseases like Dravet syndrome.
Cowen’s latest Therapeutic Categories Outlook and the IQVIA Institute’s Global Use of Medicine in 2019 and Outlook to 2023 both forecast pharmaceutical sales growth in the middle single digits (CAGR) over the next five years. Lippincott Library has several tools to help you discover areas of emerging therapeutic interest by screening for drugs in development and biopharmaceutical deals.
BCIQ from BioCentury has a number of different ways to find information on drugs in the pipeline. BioCentury has published information and analysis related to the pharmaceutical and biotechnology sectors for over 25 years. Their profile reports allow you to quickly visualize data by company, product, disease or target. The example below shows top targets for thyroid cancer.
Selecting Companies, Products, Finance or Deals from the top menu provides many additional options for screening variables in each category.
Bloomberg’s Drug Explorer is another option for finding drugs in development. The data is supplied by Springer Nature (Adis) and can be found using the function BI PHRM DEX. The Drug Profiles tab permits screen by phase of development, status and geography, as well allowing you input a specific disease category or indication.
- Description – alternative names, registered indications, mechanisms of action and a basic explanation of the drug’s therapeutic uses.
- Timeline – information about changes in developmental phase including indication and geography, clinical trial data announcements, FDA actions and licensing changes.
- Phases – includes a table of all indications, phases and countries associated with the drug, as well as providing detailed commentary about movement between phases.
- Companies – companies associated with development of the drug, including originators and licensees
Thomson One includes Cortellis drug pipeline reports published by Clarivate Analytics. For public companies, these are available from the Company Overview under the Research; reports for non-public companies can be located by selecting Screening & Analysis, then Research and Research Search. These are lengthy predefined reports that don’t allow you choose your own screening options. For large companies, a Cortellis competitive landscape report is available, providing information about a company’s positioning in its key therapeutic areas relative to its competitors.
For more intensive research needs, Cortellis data is available via Wharton Research Data Services (WRDS). See our Pharmaceutical Industry Research Guide for additional resources focusing on this industry.
Need macroeconomic data for more than 128 countries? CEIC offers metrics including GDP, CPI, Forex rates, imports, exports, retail sales, and investment as well as premium data for Brazil, Russia, India, and China, letting you match up and download data from multiple sources for further research.
Let’s say you need to compare India’s and Russia’s gross domestic product (GDP) and quarterly imports from China from 1990 through 2015.Continue reading